Literature DB >> 2260105

Tetanus antitoxin binds to intracellular tetanus toxin in permeabilized chromaffin cells without restoring Ca2(+)-induced exocytosis.

P Marxen1, G Ahnert-Hilger, H H Wellhöner, H Bigalke.   

Abstract

Tetanus toxin blocks Ca2(+)-evoked catecholamine release from permeabilized bovine adrenal chromaffin cells preloaded with gangliosides. Tetanus toxin preincubated with its specific antibodies F(ab')2 is without any effect on exocytosis. Specific antitetanus F(ab')2 presented to chromaffin cells which are pretreated with tetanus toxin and permeabilized by digitonin cannot restore exocytosis. Under the same conditions, however, 125I-labeled F(ab')2 accumulates in chromaffin cells. The accumulation depends on the presence and concentration of tetanus toxin and can be prevented by an excess of unlabeled F(ab')2. Once tetanus toxin has initiated block of exocytosis, it cannot be neutralized by binding to its specific antibody.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260105     DOI: 10.1016/0041-0101(90)90146-x

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  Restoration of exocytosis occurs after inactivation of intracellular tetanus toxin.

Authors:  F Bartels; H Bigalke
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Distinct targets for tetanus and botulinum A neurotoxins within the signal transducing pathway in chromaffin cells.

Authors:  P Marxen; F Bartels; G Ahnert-Hilger; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

3.  Increased expression of GAD mRNA during the chronic epileptic syndrome due to intrahippocampal tetanus toxin.

Authors:  A Najlerahim; S F Williams; R C Pearson; J G Jefferys
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

4.  Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells.

Authors:  Faith C Blum; Amanda Przedpelski; William H Tepp; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.